# Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma

> **NCT03338166** · — · UNKNOWN · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **OTHER:** LDH serum level

## Key facts

- **NCT ID:** NCT03338166
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-02
- **Primary completion:** 2018-07
- **Final completion:** 2018-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03338166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03338166, "Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03338166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*